Safety of recombinant human deoxyribonuclease as a rescue treatment for persistent atelectasis in newborns

Abstract excerpt

BACKGROUND AND OBJECTIVE: Pulmonary problems are vitally important in newborns. Increased intense and mucoid secretions may lead to atelectasis, pulmonary infections, respiratory distress, prolonged mechanical ventilation or even death. The aim of this study was to evaluate the safety of recombinant human deoxyribonuclease (rhDNase) in the management of persistent atelectasis in term and preterm newborns,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cystic Fibrosis Research Advances
• Share to Neonatal and Maternal Infections
• Share to Neonatal Respiratory Health Research